Kayvan Mohkam, Paul-Noël Dumont, Anne-Frédérique Manichon, Jean-Christophe Jouvet, Loïc Boussel, Philippe Merle, Christian Ducerf, Mickaël Lesurtel, Agnès Rode, Jean-Yves Mabrut
BACKGROUND: No touch multibipolar radiofrequency ablation (NTM-RFA) represents a novel therapy that surpasses standard RFA for hepatocellular carcinoma (HCC), but it was never compared to surgical resection (SR). We aimed to compare outcomes of NTM-RFA and SR for intermediate-sized HCC. METHODS: Between 2012 and 2016, outcomes of patients primarily treated for solitary HCC ranging from 2 to 5 cm by NTM-RFA or SR at a single-center were compared using inverse probability of treatment weighting (IPTW)...
February 1, 2018: Journal of Hepatology